(Q33560369)

English

Potential cost savings of oral versus intravenous etoposide in the treatment of small cell lung cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Potential cost savings of oral versus intravenous etoposide in the treatment of small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

author name string

Pashko S

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Johnson DH

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 1992

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

293-297

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomics of intravenous drug administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination cyclophosphamide and etoposide in treatment of small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide (VP-16) in the treatment of lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VP-16-213 (etoposide): the mandrake root from Issyk-Kul

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide (VP-16-213). Current status of an active anticancer drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199201040-00006

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33560369&oldid=2195490935"